↓ Skip to main content

Teprotumumab for the Treatment of Active Thyroid Eye Disease

Overview of attention for article published in New England Journal of Medicine, January 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Citations

dimensions_citation
428 Dimensions

Readers on

mendeley
227 Mendeley